Cargando…

MG53: A potential therapeutic target for kidney disease

Ensuring cell survival and tissue regeneration by maintaining cellular integrity is important to the pathophysiology of many human diseases, including kidney disease. Mitsugumin 53 (MG53) is a member of the tripartite motif‐containing (TRIM) protein family that plays an essential role in repairing c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Ben, Shen, Wen, Song, Jianling, Fang, Xiangdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801490/ https://www.ncbi.nlm.nih.gov/pubmed/36583464 http://dx.doi.org/10.1002/prp2.1049

Ejemplares similares

Roles of interferon regulatory factor 4 in the AKI-CKD transition, glomerular diseases and kidney allograft rejection
por: Song, Jianling, et al.
Publicado: (2023)

Is MG53 a potential therapeutic target for cancer?
por: Du, Yunyu, et al.
Publicado: (2023)

Identification of immune-related molecular clusters and diagnostic markers in chronic kidney disease based on cluster analysis
por: Yan, Peng, et al.
Publicado: (2023)

The NLPR3 inflammasome and obesity‐related kidney disease
por: Ke, Ben, et al.
Publicado: (2017)

Association of nocturia of self-report with estimated glomerular filtration rate: a cross-sectional study from the NHANES 2005–2018
por: Song, Jianling, et al.
Publicado: (2023)

Dickkopf-3: Current Knowledge in Kidney Diseases
por: Fang, Xiangdong, et al.
Publicado: (2020)

Ion channels as a therapeutic target for renal fibrosis
por: Yan, Peng, et al.
Publicado: (2022)

Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases
por: Li, Jinghan, et al.
Publicado: (2023)

Targeting HMGB1: A Potential Therapeutic Strategy for Chronic Kidney Disease
por: Liu, Tongtong, et al.
Publicado: (2023)

Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
por: Martinez-Moreno, Julio M., et al.
Publicado: (2020)

Inhibition of HDAC6 activity in kidney diseases: a new perspective
por: Ke, Ben, et al.
Publicado: (2018)

p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma
por: Teoh, P. J., et al.
Publicado: (2014)

The Growth Factors: Potential Biomarkers and Therapeutic Targets in Kidney Diseases
por: Tang, Wei, et al.
Publicado: (2022)

Kidney disease models: tools to identify mechanisms and potential therapeutic targets
por: Bao, Yin-Wu, et al.
Publicado: (2018)

Cardiac effects and clinical applications of MG53
por: Zhong, Weina, et al.
Publicado: (2021)

The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target
por: Fierabracci, Alessandra, et al.
Publicado: (2016)

Krüppel-like Factor 15: A Potential Therapeutic Target For Kidney Disease
por: Wang, Lefeng, et al.
Publicado: (2019)

The role of the farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases
por: Kim, Dong-Hyun, et al.
Publicado: (2023)

Alterations of amplitude of low-frequency fluctuations and fractional amplitude of low-frequency fluctuations in end-stage renal disease on maintenance dialysis: An activation likelihood estimation meta-analysis
por: Cao, Huiling, et al.
Publicado: (2022)

Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease
por: Trambas, Inez A., et al.
Publicado: (2023)

Short-term blood pressure variability as a potential therapeutic target for kidney disease
por: Ko, Ye Eun, et al.
Publicado: (2023)

Ferroptosis: A Potential Therapeutic Target in Acute Kidney Injury
por: Hosohata, Keiko, et al.
Publicado: (2022)

The therapeutic potential of apelin in kidney disease
por: Chapman, Fiona A., et al.
Publicado: (2021)

MG53′s new identity
por: Levy, Jennifer R, et al.
Publicado: (2013)

Therapeutic Potential of Photobiomodulation for Chronic Kidney Disease
por: Bian, Ji, et al.
Publicado: (2022)

Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC
por: Zhang, Yaqun, et al.
Publicado: (2019)

Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases
por: Zhang, Weihuang, et al.
Publicado: (2020)

p53 Isoforms as Cancer Biomarkers and Therapeutic Targets
por: Zhao, Liuqun, et al.
Publicado: (2022)

Anticancer Therapeutic Strategies Targeting p53 Aggregation
por: Ferretti, Giulia D. S., et al.
Publicado: (2022)

Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury
por: Uddin, Md Jamal, et al.
Publicado: (2020)

Ferroptosis: A potential therapeutic target in autoimmune disease (Review)
por: Shen, Liang, et al.
Publicado: (2023)

Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
por: Toth-Manikowski, Stephanie, et al.
Publicado: (2015)

Smads as therapeutic targets for chronic kidney disease
por: Lan, Hui Yao
Publicado: (2012)

A potential therapeutic strategy for prostatic disease by targeting the oral microbiome
por: Fang, Cheng, et al.
Publicado: (2020)

Transcription Factors as Therapeutic Targets in Chronic Kidney Disease
por: Hishikawa, Akihito, et al.
Publicado: (2018)

Therapeutic Approaches Targeting Proteostasis in Kidney Disease and Fibrosis
por: Chen, Jia-Huang, et al.
Publicado: (2021)

LncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis via miR‐16‐5p/ACSL4 axis to alleviate diabetic nephropathy
por: Fang, Xiangdong, et al.
Publicado: (2023)

Src Family Kinases: A Potential Therapeutic Target for Acute Kidney Injury
por: Li, Nannan, et al.
Publicado: (2022)

TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
por: Zixin, Ye, et al.
Publicado: (2022)

Mitochondria: a new therapeutic target in chronic kidney disease
por: Granata, Simona, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gktegr7emj8q531kun96rkfrrh